4//SEC Filing
Grant Stuart 4
Accession 0001127602-10-016469
CIK 0000882796other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 1:21 PM ET
Size
8.3 KB
Accession
0001127602-10-016469
Insider Transaction Report
Form 4
Grant Stuart
SR VP & CFO
Transactions
- Sale
Common Stock
2010-06-03$6.97/sh−1,250$8,713→ 11,717 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2010-06-03−1,250→ 106,251 totalExercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (1,250 underlying) - Exercise/Conversion
Common Stock
2010-06-03$1.20/sh+1,250$1,500→ 12,967 total
Footnotes (1)
- [F1]Transacted under a 10b5-1 plan that was adopted on 11/23/2009.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001410397
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 1:21 PM ET
- Size
- 8.3 KB